Cited by 226Protease and Inhibitor MechanismsInflammatory Bowel DiseaseBlood Coagulation and Thrombosis Mechanisms

Protease inhibition as new therapeutic strategy for GI diseases

Open access
Vergnolle, Nathalie·2016·Gut

Abstract

The GI tract is the most exposed organ to proteases, both in physiological and pathophysiological conditions. For digestive purposes, the lumen of the upper GI tract contains large amounts of pancreatic proteases, but studies have also demonstrated increased proteolytic activity into mucosal tissues (both in the upper and lower GI tract), associated with pathological conditions. This review aims at outlining the evidences for dysregulated proteolytic homeostasis in GI diseases and the pathogenic mechanisms of increased proteolytic activity. The therapeutic potential of protease inhibition in GI diseases is discussed, with a particular focus on IBDs, functional GI disorders and colorectal cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2015-309147

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Host proteases such as chymase or ELA2A are able to cleave tight and adherens junction proteins including zonula occludens-1 or E-cadherin.

    “Host proteases such as chymase or ELA2A are able to cleave tight and adherens junction proteins including zonula occludens-1 or E-cadherin.22,29,130”
  • Activation of the different members of the PAR family is protease specific, tightly regulated and influences physiological functions in the gut such as motility, permeability and nociception.

    “The activation of the different members of the PAR family (PAR-1, 2,3 and 4) is protease specific, tightly regulated and influences a number of physiological functions in the gut such as motility, permeability and nociception.22”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vergnolle, N.
Affiliations
Université Toulouse III - Paul Sabatier (FR)
Corresponding author
Vergnolle, Nathalie
Venue
Gut
Publisher
BMJ
Published
2016-04-12
Volume
65
Issue
7
Pages
1215-1224
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2335993428
Cited by
226
References
105
Citations by year
2026: 12 · 2025: 24 · 2024: 22 · 2023: 20 · 2022: 27 · 2021: 35 · 2020: 19 · 2019: 26 · 2018: 21 · 2017: 13 · 2016: 5 · 2015: 1
FWCI
1.99
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Gut (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by-nc)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Agence Nationale de la Recherche (R12177BB)
  • Association Francois Aupetit
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
protease inhibition, gastrointestinal diseases, intestinal mucosa, pancreatic proteases, inflammatory bowel disease, functional gastrointestinal disorders, colorectal cancer, treatment options
MeSH terms
Animals, Celiac Disease, Gastrointestinal Diseases, Humans, Peptide Hydrolases, Protease Inhibitors, Colorectal Neoplasms, Inflammatory Bowel Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review